Gene · 4738
Papers3,078
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,078
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Modular Biosensor Design for Quantitative Measurement of Free Nedd8. | ACS Sens | 2024 | 39253816 | PubTator, text mining | PubMed |
| Proteome asymmetry in mouse and human embryos before fate specification. | bioRxiv | 2024 | 39253500 | PubTator, text mining | PubMed |
| Discovery of small molecule inhibitors of neddylation catalyzing enzymes for anticancer therapy. | Biomed Pharmacother | 2024 | 39214012 | PubTator, text mining | PubMed |
| Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients. | Transl Oncol | 2024 | 39182365 | PubTator, text mining | PubMed |
| UBE2M forms a positive feedback loop with estrogen receptor to drive breast cancer progression and drug resistance. | Cell Death Dis | 2024 | 39138151 | PubTator, text mining | PubMed |
| Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615). | Eur J Cancer | 2024 | 39096851 | PubTator, text mining | PubMed |
| Vaccinia virus F1L blocks the ribotoxic stress response to subvert ZAKα-dependent NLRP1 inflammasome activation. | Eur J Immunol | 2024 | 39086059 | PubTator, text mining | PubMed |
| Induction of the Mdm2 gene and protein by kinase signaling pathways is repressed by the pVHL tumor suppressor. | Proc Natl Acad Sci U S A | 2024 | 39047034 | PubTator, text mining | PubMed |
| Biochemical and Structural Consequences of NEDD8 Acetylation. | Chembiochem | 2024 | 39022855 | PubTator, text mining | PubMed |
| Diversity of structure and function in Cullin E3 ligases. | Curr Opin Struct Biol | 2024 | 39013361 | PubTator, text mining | PubMed |
| TRAF2 associates with cullin neddylation complex assembly. | FEBS J | 2024 | 38978293 | PubTator, text mining | PubMed |
| Unconventional posttranslational modification in innate immunity. | Cell Mol Life Sci | 2024 | 38970666 | PubTator, text mining | PubMed |
| Neddylation activated TRIM25 desensitizes triple-negative breast cancer to paclitaxel via TFEB-mediated autophagy. | J Exp Clin Cancer Res | 2024 | 38926803 | PubTator, text mining | PubMed |
| Unveiling shared biomarkers and therapeutic targets between systemic lupus erythematosus and heart failure through bioinformatics analysis. | Front Med (Lausanne) | 2024 | 38912340 | PubTator, text mining | PubMed |
| DCUN1D1 and neddylation: Potential targets for cancer therapy. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38885797 | PubTator, text mining | PubMed |
| The Role of Neddylation in Malaria Parasites. | DNA Cell Biol | 2024 | 38885136 | PubTator, text mining | PubMed |
| RAPSYN-mediated neddylation of BCR-ABL alternatively determines the fate of Philadelphia chromosome-positive leukemia. | Elife | 2024 | 38865175 | PubTator, text mining | PubMed |
| Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer. | NPJ Breast Cancer | 2024 | 38802426 | PubTator, text mining | PubMed |
| Targeted degradation of oncogenic BCR-ABL by silencing the gene of NEDD8 E3 ligase RAPSYN. | J Nanobiotechnology | 2024 | 38741123 | PubTator, text mining | PubMed |
| Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer. | Nat Commun | 2024 | 38678024 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4738/papers?page=8